Improving diabetes care for high-risk patients with latent tuberculosis
Prospective Quality Improvement Project for High-Risk Diabetes Patients
This study tests whether better education and monitoring can help diabetic patients in Taiwan manage their blood sugar while they are being treated for latent tuberculosis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 20 Years to 99 Years |
| Sex | All |
| Sponsor | Taipei Medical University WanFang Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06472609 on ClinicalTrials.gov |
What this trial studies
This project focuses on diabetic patients in Taiwan who are at high risk for latent tuberculosis infection. It aims to enhance the quality of care by implementing interactive education and continuous glucose monitoring to assess blood sugar fluctuations during tuberculosis treatment. The study will evaluate the impact of tuberculosis medications on blood sugar levels and overall patient safety. By addressing the intersection of diabetes management and tuberculosis treatment, the project seeks to improve patient outcomes and reduce transmission risks.
Who should consider this trial
Good fit: Ideal candidates for this study are diabetic patients with a glycated hemoglobin (HbA1C%) greater than 9% in the past year.
Not a fit: Patients under 20 years old or those with severe cognitive impairments who cannot complete quality of life assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this project could lead to better management of diabetes in patients undergoing treatment for latent tuberculosis, ultimately improving their quality of life.
How similar studies have performed: Other studies have shown the importance of managing diabetes in patients with tuberculosis, but this specific approach of integrating continuous glucose monitoring with tuberculosis treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diabetic patients had a record of glycated hemoglobin (HbA1C%) greater than 9% in the past year. Exclusion Criteria: * Be younger than 20 years old. * Unconsciousness or severe dementia, unable to conduct quality of life questionnaire assessment.
Where this trial is running
Taipei
- Chih-Hsin,Lee — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Chih-Hsin Lee
- Email: chleetw@tmu.edu.tw
- Phone: 0970746523
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.